Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Enanta Pharmaceuticals Inc shares valued at $256,050 were purchased by Luly Jay R. on Feb 12 ’25. At $5.69 per share, Luly Jay R. acquired 45,000 shares. The insider’s holdings grew to 846,638 shares worth approximately $7.03 million following the completion of this transaction.
Also, Kieffer Tara Lynn sold 2,283 shares, netting a total of over 18,401 in proceeds. Following the sale of shares at $8.06 each, the insider now holds 29,305 shares.
Before that, Luu Brendan had sold 2,283 shares from its account. In a trade valued at $18,401, the Chief Business Officer traded Enanta Pharmaceuticals Inc shares for $8.06 each. Upon closing the transaction, the insider’s holdings decreased to 2,283 shares, worth approximately $0.3 million.
As published in a research note from JP Morgan on August 09, 2023, Enanta Pharmaceuticals Inc [ENTA] has been rated down from a Neutral to an Underweight and the price target has been revised to $14. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early August. As of December 09, 2022, H.C. Wainwright has initiated its “Buy” rating for ENTA. Earlier on July 06, 2022, Evercore ISI upgraded its rating. Their new recommendation was “an Outperform” for ENTA stock which previously was a “an In-line”.
Analyzing ENTA Stock Performance
During the last five days, there has been a surge of approximately 48.48%. Over the course of the year, Enanta Pharmaceuticals Inc shares have jumped approximately 44.35%. Shares of the company reached a 52-week high of $8.55 on 02/19/25 and a 52-week low of $4.71 on 01/16/25. A 50-day SMA is recorded $5.91, while a 200-day SMA reached $10.67. Nevertheless, trading volume fell to 0.85 million shares from 0.53 million shares the previous day.
Support And Resistance Levels for Enanta Pharmaceuticals Inc (ENTA)
According to the 24-hour chart, there is a support level at 7.59, which, if violated, would cause prices to drop to 6.88. In the upper region, resistance lies at 8.78. The next price resistance is at 9.26. RSI (Relative Strength Index) is 76.83 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.77, which suggests the price will increase in the coming days. Percent R is at 6.54%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
